CME GROUP INC.

CME

CME GROUP INC.

CME

Insider Sentiment (TTM):

Last Purchase:2026-06-25Last Sale:2026-05-18Shares Purchased (TTM):99.01Shares Sold (TTM):101,695

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:298,491,556Shares Outstanding:359,318,000Institutional Ownership Pct.:83.07%

Earnings Market Reaction:

Filing Date:2026-07-24Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Security & Commodity Brokers, Dealers, Exchanges & Services

ICE NDAQ CBOE TW LPLA SNEX

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	2,144	2,391	4,417	2,447	1,981	1,405	2,892	2,322	1,790	1,437	2,912	2,300
Marketable Securities Current	131	124	125	123	118	114	113	112	122	121	112	104
Accounts Receivable Net Current	753	936	639	643	668	770	573	629	600	628	536	558
Other Assets Current	492	515	522	547	526	462	559	622	568	648	1,138	622
Good Faith And Margin Deposits With Broker Dealers	158,111	165,035	159,656	149,041	142,158	120,695	98,895	99,457	85,670	94,474	90,193	87,192
Assets Current	161,631	169,001	165,359	152,801	145,450	123,445	103,034	103,143	88,749	97,308	94,890	90,777
Property Plant And Equipment Net	351	355	363	355	363	371	386	386	385	396	410	417
Other Indefinite Lived Intangible Assets	-	-	17,175	-	-	-	17,175	-	-	-	17,175	-
Finite Lived Intangible Assets Net	2,045	2,551	2,611	2,668	2,729	2,773	2,822	2,892	2,933	2,990	3,050	3,095
Goodwill	10,506	10,506	10,515	10,515	10,524	10,500	10,487	10,514	10,489	10,490	10,495	10,478
Other Assets Noncurrent	2,519	2,405	2,402	3,631	3,666	3,567	3,544	3,685	3,650	3,695	3,686	3,656
Assets	194,677	201,994	198,424	187,145	179,907	157,832	137,447	137,795	123,379	132,054	129,706	125,598
Accounts Payable Current	68	75	72	75	92	100	80	130	100	111	91	54
Short Term Borrowings	-	-	0	0	0	0	750	750	750	749	0	0
Other Liabilities Current	539	887	569	471	545	626	2,589	485	455	767	3,134	635
Liabilities Current	158,717	165,998	160,297	149,587	142,795	121,420	102,314	100,822	86,974	96,101	93,417	87,881
Unsecured Long Term Debt	3,424	3,423	3,422	3,421	3,420	3,419	2,678	2,678	2,677	2,677	3,425	3,425
Deferred Income Tax Liabilities Net	5,221	5,221	5,242	5,220	5,233	5,240	5,247	5,310	5,309	5,317	5,328	5,333
Other Liabilities Noncurrent	794	733	735	726	720	721	721	769	783	804	798	809
Liabilities	168,156	175,375	169,696	158,954	152,168	130,801	110,960	109,579	95,744	104,900	102,968	97,447
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	21,004	21,671	22,210	22,437	22,435	22,416	22,403	22,375	22,372	22,346	22,335	22,309
Retained Earnings Accumulated Deficit	5,458	4,885	6,433	5,706	5,255	4,686	4,186	5,848	5,355	4,891	4,455	5,956
Accumulated Other Comprehensive Income Loss Net Of…	55	59	82	43	45	-75	-106	-11	-95	-86	-56	-117
Stockholders Equity	26,520	26,618	28,728	28,190	27,739	27,031	26,487	28,216	27,636	27,154	26,738	28,152
Liabilities And Stockholders Equity	194,677	201,994	198,424	187,145	179,907	157,832	137,447	137,795	123,379	132,054	129,706	125,598
Allowance For Doubtful Accounts Receivable Current	9	10	-	9	10	9	-	9	9	8	-	8
Restricted Cash And Cash Equivalents At Carrying V…	4	6	-	7	7	6	-	7	5	5	-	5
Accumulated Depreciation Depletion And Amortizatio…	994	1,028	-	983	961	956	-	1,012	985	959	-	904
Restricted Cash And Cash Equivalents Noncurrent	-	0	-	0	0	0	-	0	0	0	-	0
Preferred Stock Par Or Stated Value Per Share	0.01	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock Shares Authorized	10	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock Shares Issued	0	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock Shares Outstanding	0	-	-	-	-	-	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.84%	-4.96%	-15.28%	-	-	-	-	-	-	-	-	-
2025	2.52%	-0.66%	-0.40%	-2.01%	-5.72%	-2.43%	5.75%	1.96%	-2.18%	-0.56%	-6.93%	-3.30%
2024	3.29%	-5.99%	-3.40%	9.39%	11.27%	15.26%	5.47%	6.56%	7.10%	5.92%	5.59%	11.13%
2023	-	-	-	1.78%	1.58%	7.16%	2.97%	2.13%	-1.30%	-2.36%	-3.02%	-2.98%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.02	1.02	1.03	1.02	1.02	1.02	1.01	1.02	1.02	1.01	1.02	1.03
Quick Ratio	1.02	1.02	1.03	1.02	1.02	1.02	1.01	1.02	1.02	1.01	1.02	1.03
Working Capital	2.91B	3.00B	5.06B	3.21B	2.66B	2.03B	719.60M	2.32B	1.77B	1.21B	1.47B	2.90B
Leverage & Debt
Debt to Equity	6.34	6.59	5.91	5.64	5.49	4.84	4.19	3.88	3.46	3.86	3.85	3.46
Interest Coverage TTM	25.21	25.28	24.39	24.40	25.26	25.08	24.43	24.06	22.87	21.84	21.55	20.31
Debt Ratio	0.86	0.87	0.86	0.85	0.85	0.83	0.81	0.80	0.78	0.79	0.79	0.78
Efficiency & Turnover
Asset Turnover TTM	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.05	0.04	0.04	0.04	0.04
Days Sales Outstanding TTM	38.28	46.06	33.93	36.30	35.89	40.61	33.01	35.87	37.74	43.86	33.33	38.86
Receivables Turnover TTM	9.53	7.92	10.76	10.06	10.17	8.99	11.06	10.18	9.67	8.32	10.95	9.39
Per Share Metrics
Diluted EPS TTM	11.97	11.86	11.34	10.47	10.49	10.06	9.80	9.51	9.06	8.77	8.86	8.42
Free Cash Flow Per Share TTM	11.68	12.05	11.66	11.35	11.42	10.64	10.01	10.10	9.72	9.36	9.41	9.22
Dividend Per Share TTM	11.30	11.31	10.94	10.83	10.73	10.63	9.97	9.92	9.87	9.82	9.01	8.91
Margin Metrics
Gross Profit Margin TTM	86.19%	86.34%	86.09%	86.14%	86.53%	86.46%	86.13%	86.06%	85.70%	85.24%	85.15%	84.88%
Operating Profit Margin TTM	65.10%	65.57%	64.86%	64.98%	65.31%	64.92%	64.13%	63.66%	62.85%	61.89%	61.58%	60.61%
Net Profit Margin TTM	63.87%	63.76%	62.65%	58.99%	58.64%	57.69%	57.52%	56.62%	56.26%	56.13%	57.10%	56.63%
Growth Metrics
Net Revenue Growth (1Y)	5.10%	7.54%	6.37%	5.84%	11.15%	11.72%	9.88%	13.03%	10.69%	9.99%	11.15%	7.83%
Net Income Growth (1Y)	14.48%	18.85%	15.86%	10.28%	15.85%	14.83%	10.68%	13.01%	9.93%	10.33%	18.38%	13.44%
EPS Growth (1Y)	14.15%	18.94%	15.78%	10.19%	15.75%	14.72%	10.57%	12.89%	9.81%	10.23%	18.28%	13.34%
Valuation Metrics
P/E TTM	18.41	24.50	23.36	24.91	25.25	25.21	22.57	21.46	19.95	22.43	21.62	20.99
P/B TTM	3.00	3.97	3.32	3.33	3.44	3.38	3.00	2.60	2.35	2.61	2.58	2.26
P/S TTM	11.76	15.62	14.63	14.69	14.81	14.55	12.98	12.15	11.22	12.59	12.35	11.89
Market Cap	79.65B	105.58B	95.42B	93.99B	95.42B	91.41B	79.58B	73.42B	65.07B	70.83B	68.88B	63.56B
Enterprise Value	-77.19B	-58.43B	-65.23B	94.97B	-45.31B	-27.28B	80.11B	74.53B	-18.97B	72.82B	69.39B	64.68B
Calculated Values
Free Cash Flow TTM	4.21B	4.33B	4.19B	4.08B	4.11B	3.83B	3.60B	3.63B	3.49B	3.36B	3.38B	3.31B
Net Debt	-156.84B	-164.01B	-160.66B	974.50M	-140.73B	-118.69B	535.60M	1.11B	-84.04B	1.99B	513.40M	1.12B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Purchase

Owner: Shepard, William R

Title: -

Shares: 14

Price/Share: $230.57

Value: $3,301.76

Shares Owned: 3,621

Relationship: Director

Ownership: Direct

2026-05-18Sale

Owner: Piell, Hilda Harris

Title: Sr MD & Chief HR Officer

Shares: 5,753

Price/Share: $304.63

Value: $1,752,536.39

Shares Owned: 27,702

Relationship: Officer

Ownership: Direct

2026-05-15Sale

Owner: Duffy, Terrence A

Title: Chairman and CEO

Shares: 35,000

Price/Share: $298.86

Value: $10,460,100.00

Shares Owned: 55,630

Relationship: Director,Officer

Ownership: Direct

2026-03-26Purchase

Owner: Shepard, William R

Title: -

Shares: 62

Price/Share: $297.38

Value: $18,455.40

Shares Owned: 2,539

Relationship: Director

Ownership: Direct

2026-03-17Sale

Owner: Marcus, Jonathan L

Title: Sr MD General Counsel

Shares: 3,291

Price/Share: $313.37

Value: $1,031,300.67

Shares Owned: 7,192

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Shepard, William R	Director	-	Direct	Purchase	14	230.57	$3,301.76	3,621	4
2026-05-18	Piell, Hilda Harris	Officer	Sr MD & Chief HR Officer	Direct	Sale	5,753	304.63	$1,752,536.39	27,702	4
2026-05-15	Duffy, Terrence A	Director,Officer	Chairman and CEO	Direct	Sale	35,000	298.86	$10,460,100.00	55,630	4
2026-03-26	Shepard, William R	Director	-	Direct	Purchase	62	297.38	$18,455.40	2,539	4
2026-03-17	Marcus, Jonathan L	Officer	Sr MD General Counsel	Direct	Sale	3,291	313.37	$1,031,300.67	7,192	4/A
2026-03-12	Vroman, Ken	Officer	Chief Transformation Officer	Direct	Sale	5,160	309.00	$1,594,440.00	14,910	4
2026-03-06	Cook, Elizabeth A	Director	-	Indirect	Sale	1,000	320.00	$320,000.00	17,771	4
2026-02-23	Durkin, Bryan T	Director	-	Direct	Sale	4,200	309.65	$1,300,530.00	43,007	4
2026-02-20	Gepsman, Martin J	Director	-	Direct	Sale	300	305.90	$91,770.00	24,999	4
2026-02-06	Suskind, Dennis	Director	-	Direct	Sale	748	300.00	$224,400.00	2,699	4
2025-12-30	Shepard, William R	Director	-	Direct	Purchase	11	278.37	$3,078.77	2,477	4
2025-12-11	Duffy, Terrence A	Director,Officer	Chairman and CEO	Direct	Sale	25,000	269.58	$6,739,500.00	65,804	4
2025-11-20	Sammann, Derek	Officer	Sr MD Gl Hd Commodities Mkts	Indirect	Sale	7,200	275.70	$1,985,040.00	7,022	4
2025-11-03	Ford, Harold Eugene Jr.	Director	-	Direct	Sale	1,000	263.53	$263,530.00	1,091	4
2025-09-25	Shepard, William R	Director	-	Direct	Purchase	12	265.22	$3,068.60	2,466	4
2025-09-18	Marcus, Jonathan L	Officer	Sr MD General Counsel	Direct	Sale	392	262.00	$102,704.00	7,851	4
2025-09-16	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	379	259.83	$98,475.57	9,508	4
2025-09-16	Marcus, Jonathan L	Officer	Sr MD General Counsel	Direct	Sale	376	258.96	$97,368.96	8,537	4
2025-08-26	Cutinho, Sunil	Officer	Chief Information Officer	Direct	Sale	11,896	271.48	$3,229,526.08	17,440	4
2025-06-25	Shepard, William R	Director	-	Direct	Purchase	11	270.53	$3,054.28	2,455	4
2025-06-10	Carey, Charles P	Director	-	Indirect	Sale	500	265.36	$132,680.00	4,900	4
2025-05-22	Kaye, Daniel G	Director	-	Direct	Sale	500	282.42	$141,210.00	3,668	4
2025-05-20	Marcus, Jonathan L	Officer	Sr MD General Counsel	Direct	Sale	390	277.50	$108,225.00	6,708	4
2025-05-19	Lockett, Phyllis M	Director	-	Direct	Sale	1,060	277.88	$294,552.80	3,108	4
2025-05-15	Carey, Charles P	Director	-	Indirect	Sale	3,000	272.56	$817,680.00	5,400	4
2025-05-15	Gepsman, Martin J	Director	-	Direct	Sale	300	273.17	$81,951.00	24,767	4
2025-05-05	Sammann, Derek	Officer	Sr MD Gl Hd Commodities Mkts	Indirect	Sale	4,650	280.62	$1,304,883.00	8,336	4
2025-04-29	Suskind, Dennis	Director	-	Direct	Sale	1,000	271.28	$271,280.00	2,915	4
2025-04-25	Gerdes, Larry G	Director	-	Direct	Sale	2,000	266.12	$532,240.00	36,651	4
2025-03-26	Shepard, William R	Director	-	Direct	Purchase	12	262.62	$3,041.14	2,443	4
2025-03-14	Lucas, Deborah J	Director	-	Direct	Sale	1,500	256.95	$385,425.00	3,356	4
2025-03-13	Siegel, Howard J	Director	-	Indirect	Sale	10,000	260.00	$2,600,000.00	21,873	4
2025-03-11	Duffy, Terrence A	Director,Officer	Chairman and CEO	Direct	Sale	30,000	259.18	$7,775,400.00	53,205	4
2025-03-03	Sprague, Suzanne	Officer	COO & Global Head of Clearing	Direct	Sale	1,500	256.83	$385,245.00	8,036	4
2025-02-27	Piell, Hilda Harris	Officer	Sr MD & Chief HR Officer	Direct	Sale	3,984	250.47	$997,872.48	27,046	4
2025-02-13	Winkler, Julie	Officer	Sr MD Chief Commercial Officer	Direct	Sale	11,592	249.17	$2,888,378.64	21,885	4
2025-02-13	Vroman, Ken	Officer	Chief Transformation Officer	Direct	Sale	5,066	250.00	$1,266,500.00	16,715	4
2025-01-16	Shepard, William R	Director	-	Direct	Purchase	60	227.96	$13,689.00	2,432	4/A
2024-12-27	Shepard, William R	Director	-	Direct	Purchase	12	232.89	$2,715.50	2,372	4
2024-12-27	Benesh, Kathryn	Director	-	Direct	Purchase	8	232.77	$1,801.64	1,575	5
2024-11-12	Cook, Elizabeth A	Director	-	Indirect	Sale	750	226.33	$169,747.50	18,239	4
2024-11-04	Gepsman, Martin J	Director	-	Direct	Sale	400	222.92	$89,168.00	25,067	4
2024-10-30	Bitsberger, Timothy S.	Director	-	Direct	Sale	1,000	226.96	$226,960.00	10,589	4
2024-10-30	Cutinho, Sunil	Officer	Chief Information Officer	Direct	Sale	4,500	226.64	$1,019,880.00	27,053	4
2024-10-28	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	1,374	227.12	$312,062.88	7,275	4
2024-09-25	Shepard, William R	Director	-	Direct	Purchase	12	218.50	$2,700.66	2,360	4
2024-09-15	Fitzpatrick, Lynne	Officer	Sr MD Chief Financial Officer	Direct	Sale	754	216.99	$163,610.46	13,261	4
2024-08-30	Durkin, Bryan T	Director	-	Direct	Sale	7,593	214.59	$1,629,381.87	55,607	4
2024-06-25	Shepard, William R	Director	-	Direct	Purchase	14	195.07	$2,684.16	2,348	4
2024-06-13	Carey, Charles P	Director	-	Indirect	Sale	3,000	195.44	$586,320.00	7,163	4
2024-06-06	Glickman, Daniel R	Director	-	Direct	Sale	650	201.44	$130,936.00	14,008	4
2024-05-20	Cook, Elizabeth A	Director	-	Indirect	Sale	1,000	211.52	$211,520.00	18,241	4
2024-05-13	Savage, Terry L	Director	-	Indirect	Sale	2,500	210.65	$526,625.00	17,441	4
2024-05-08	Piell, Hilda Harris	Officer	Sr MD & Chief HR Officer	Direct	Sale	7,140	210.37	$1,502,041.80	29,256	4
2024-04-29	Duffy, Terrence A	Director,Officer	Chairman and CEO	Direct	Sale	40,000	210.39	$8,415,600.00	67,455	4
2024-03-26	Shepard, William R	Director	-	Direct	Purchase	12	214.71	$2,670.99	2,334	4
2024-03-15	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	556	217.50	$120,930.00	6,865	4
2024-01-31	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	35	206.78	$7,237.30	6,447	4
2024-01-18	Shepard, William R	Director	-	Direct	Purchase	59	202.44	$11,881.20	2,322	4
2023-12-28	Shepard, William R	Director	-	Direct	Purchase	12	210.79	$2,476.78	2,263	4
2023-12-11	Durkin, Bryan T	Director	-	Direct	Sale	5,560	216.37	$1,203,017.20	62,452	4
2023-12-04	Sammann, Derek	Officer	Sr MD Gl Hd Commodity & Option	Indirect	Sale	1,862	222.07	$413,494.34	0	4
2023-11-06	Suskind, Dennis	Director	-	Direct	Sale	1,500	213.60	$320,400.00	3,167	4
2023-10-31	Sprague, Suzanne	Officer	Sr MD Global Head of Clearing	Direct	Sale	1,146	211.79	$242,711.34	6,972	4
2023-10-31	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	43	213.18	$9,166.74	6,309	4
2023-10-30	Cook, Elizabeth A	Director	-	Indirect	Sale	500	211.43	$105,715.00	19,241	4
2023-10-27	Cook, Elizabeth A	Director	-	Indirect	Sale	500	208.22	$104,110.00	19,741	4
2023-10-26	Mccourt, Timothy Francis	Officer	Sr MD Global Head Equity & FX	Direct	Sale	1,043	216.37	$225,673.91	6,352	4
2023-10-26	Gepsman, Martin J	Director	-	Direct	Sale	300	216.33	$64,899.00	24,719	4
2023-10-10	Carey, Charles P	Director	-	Indirect	Sale	1	216.09	$216.09	0	5
2023-09-27	Shepard, William R	Director	-	Direct	Purchase	12	199.84	$2,462.03	2,251	4
2023-08-18	Duffy, Terrence A	Director,Officer	Chairman and CEO	Direct	Sale	30,000	203.95	$6,118,500.00	65,545	4
2023-08-15	Holzrichter, Julie	Officer	Sr MD Chief Operating Officer	Direct	Sale	6,000	205.47	$1,232,820.00	31,990	4
2023-08-11	Bitsberger, Timothy S.	Director	-	Direct	Sale	800	205.34	$164,272.00	10,841	4
2023-08-10	Winkler, Julie	Officer	Sr MD Chief Commercial Officer	Direct	Sale	6,262	207.00	$1,296,234.00	25,373	4
2023-08-09	Glickman, Daniel R	Director	-	Direct	Sale	750	206.09	$154,567.50	14,658	4
2023-08-07	Piell, Hilda Harris	Officer	Sr MD & Chief HR Officer	Direct	Sale	4,477	207.98	$931,126.46	30,900	4
2023-07-28	Cutinho, Sunil	Officer	Chief Information Officer	Direct	Sale	9,328	198.66	$1,853,100.48	23,206	4
2023-06-27	Shepard, William R	Director	-	Direct	Purchase	14	179.77	$2,448.47	2,239	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

83.07%

Inst. Shares: 298,491,556

Shares Outstanding: 359,318,000

2025-12-31

85.76%

Inst. Shares: 308,433,516

Shares Outstanding: 359,648,000

2025-09-30

84.33%

Inst. Shares: 303,308,029

Shares Outstanding: 359,686,000

2025-06-30

84.93%

Inst. Shares: 305,461,376

Shares Outstanding: 359,658,000

2025-03-31

84.42%

Inst. Shares: 303,600,762

Shares Outstanding: 359,613,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	298,491,556	359,318,000	83.07%
2025-12-31	308,433,516	359,648,000	85.76%
2025-09-30	303,308,029	359,686,000	84.33%
2025-06-30	305,461,376	359,658,000	84.93%
2025-03-31	303,600,762	359,613,000	84.42%
2024-12-31	298,676,719	359,389,000	83.11%
2024-09-30	296,657,708	359,400,000	82.54%
2024-06-30	298,623,420	359,330,000	83.11%
2024-03-31	293,868,727	359,258,000	81.80%
2023-12-31	297,917,667	359,023,000	82.98%
2023-09-30	292,266,953	359,020,000	81.41%
2023-06-30	292,926,702	358,940,000	81.61%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CME GROUP INC. (CME) — SEC Financial Statements & Analysis

CME GROUP INC. (CME) is a security & commodity brokers, dealers, exchanges & services company, incorporated in DE. CME GROUP INC. trades on Nasdaq as: CME. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CME GROUP INC. reported a 5.10% year-over-year revenue growth, a Gross Profit Margin of 86.19% (TTM), a Debt-to-Equity ratio of 6.34x, a Price-to-Sales (P/S) ratio of 11.76x (TTM), a Price-to-Book (P/B) ratio of 3 (TTM), at a market cap of $79.65B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.10%
Gross Profit Margin TTM: 86.19%
Debt To Equity: 6.34x
P/S TTM: 11.76x
P/B TTM: 3
Market Cap: $79.65B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CME GROUP INC. in?

CME GROUP INC. (CME) operates in the Security & Commodity Brokers, Dealers, Exchanges & Services industry.

What is CME's market cap?

CME GROUP INC. (CME) has a market capitalization of $79.65B as of 2026-06-30.

What is CME's P/E ratio?

CME GROUP INC. (CME)'s trailing twelve month P/E ratio is 18.41x as of 2026-06-30.

What exchange does CME trade on?

CME GROUP INC. (CME) trades on the Nasdaq.

Where is CME GROUP INC. incorporated?

CME GROUP INC. is incorporated in DE.

CME GROUP INC. (CME) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.